moxifloxacin has been researched along with Age-Related Macular Degeneration in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akova, YA; Altinors, DD; Bayar, SA; Kucukerdonmez, C | 1 |
Alabiad, CR; Davis, JL; Miller, D; Schiffman, JC | 1 |
Garg, S; Milder, E; Shah, C; Vander, J | 1 |
3 other study(ies) available for moxifloxacin and Age-Related Macular Degeneration
Article | Year |
---|---|
Severe corneal changes following intravitreal injection of bevacizumab.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aza Compounds; Bevacizumab; Choroidal Neovascularization; Corneal Edema; Descemet Membrane; Dexamethasone; Female; Fluoroquinolones; Humans; Keratitis; Macular Degeneration; Male; Moxifloxacin; Prednisolone; Quinolines; Retrospective Studies; Visual Acuity | 2010 |
Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Aza Compounds; Bacteria; Bacteriological Techniques; Conjunctiva; Drug Resistance, Bacterial; Endophthalmitis; Female; Fluoroquinolones; Humans; Intravitreal Injections; Macular Degeneration; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Nasal Mucosa; Prospective Studies; Quinolines | 2011 |
Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Case-Control Studies; Conjunctiva; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Intravitreal Injections; Macular Degeneration; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Polymyxin B; Quinolines; Trimethoprim | 2012 |